Abstract Objective: to evaluate the role of combined MDCT parameters in distinguishing benign from malignant adrenal masses in well known oncological patients. Methods: CT protocol included pre-contrast scan, venous and delayed contrast-enhanced scans assessing the mass size, pre contrast attenuation, histogram & post contrast absolute and relative percentage washout .Statistical analysis of the data was done. Results: The study included 40 patients with 44 adrenal masses. Adrenal masses included 7 lipid rich, 6 lipid poor adenomas, 7 neuroblastomas and 24 metastases. Combined CT parameters including the size (2.25 cm as cut off value), pre contrast attenuation value (Conclusion: Combining the studied CT parameters yielded a powerful diagnostic protocol in distinguishing benign from malignant adrenal masses.
(2018). MDCT combined parameters in characterization of adrenal masses in cancer patients; A prospective study in South Egypt Cancer Institute. SECI Oncology Journal, 6(4), 66-74. doi: 10.21608/secioj.2018.22179
MLA
. "MDCT combined parameters in characterization of adrenal masses in cancer patients; A prospective study in South Egypt Cancer Institute". SECI Oncology Journal, 6, 4, 2018, 66-74. doi: 10.21608/secioj.2018.22179
HARVARD
(2018). 'MDCT combined parameters in characterization of adrenal masses in cancer patients; A prospective study in South Egypt Cancer Institute', SECI Oncology Journal, 6(4), pp. 66-74. doi: 10.21608/secioj.2018.22179
VANCOUVER
MDCT combined parameters in characterization of adrenal masses in cancer patients; A prospective study in South Egypt Cancer Institute. SECI Oncology Journal, 2018; 6(4): 66-74. doi: 10.21608/secioj.2018.22179
)
View on SCiNiTO